Investigation into the effects of varying frequency of mechanical stimulation in a cycle-by-cycle manner on engineered cardiac construct function

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 2, 2017, Pages 342-353

  Morgan, Kathy Ye ^a   Black, Lauren Deems ^a,b  

^a Tufts University   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac tissue engineering; cell adaptation; contractile force; mechanical stimulation; variability

Indexed keywords

BIOCONVERSION; CELL ENGINEERING; CELLS; COPYRIGHTS; CYTOLOGY; HEART; TISSUE; TISSUE ENGINEERING;

BIOREACTOR SYSTEM; CARDIAC CONSTRUCTS; CARDIAC TISSUE ENGINEERING; CELL ADAPTATION; CONDITION; CONTRACTILE FORCE; CYCLE BASIS; MECHANICAL STIMULATION; VARIABILITY; VARIABLE FREQUENCIES;

BIOREACTORS;

ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; CALSEQUESTRIN; CALSEQUESTRIN 2; CONNEXIN 43; GAP JUNCTION PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG; FIBRIN;

ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL COMMUNICATION; CELL COUNT; CELL LOSS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART TISSUE; MECHANICAL STIMULATION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TISSUE ENGINEERING; ANIMAL; BIOREACTOR; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; HYDROGEL; MECHANICAL STRESS; PROCEDURES; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TISSUE SCAFFOLD;

ANIMALS; ANIMALS, NEWBORN; BIOREACTORS; CELL COMMUNICATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FIBRIN; HYDROGELS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84902040410     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1915     Document Type: Article

References (45)

1. Acharya UR, Joseph KP, Kannathal N. et al. 2006; Heart rate variability: a review. Med Biol Eng Comput 44(12): 1031–1051.
2. Arold SP, Bartolák-Suki E, Suki B. 2009; Variable stretch pattern enhances surfactant secretion in alveolar type II cells in culture. Mol Physiol 296(4): L574–581.
3. Birla RK, Huang YC, Dennis RG. 2007; Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng 13(9): 2239–2248.
4. Black LD, Meyers JD, Weinbaum JS. et al. 2009; Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng A 15(10): 3099–3108.
5. Boerboom RA, Rubbens MP, Driessen NJB. et al. 2008; Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Ann Biomed Eng 36(2): 244–253.
6. Buja LM, Vela D. 2008; Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol 17(6): 349–374.
7. Chaanine AH, Hajjar RJ. 2011; AKT signalling in the failing heart. Eur Journal Heart Fail 13(8): 825–829.
8. Clause KC, Tinney JP, Liu LJ. et al. 2009; Engineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38–MAP kinase phosphorylation. Tissue Eng A 15(6): 1373–1380.
9. Cysarz D, Lange S, Matthiessen PF. et al. 2007; Regular heartbeat dynamics are associated with cardiac health. Am J Physiol 292(1): R368–372.
10. DeBosch B, Treskov I, Lupu TS. et al. 2006; Akt1 is required for physiological cardiac growth. Circulation 113(17): 2097–2104.
11. Fink C, Ergün S, Kralisch D. et al. 2000; Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 14(5): 669–679.
12. Fujio Y, Nguyen T, Wencker D. et al. 2000; Akt promotes survival of cardiomyocytes in vitro and protects against ischemia–reperfusion injury in mouse heart. Circulation 101(6): 660–667.
13. Goldberger AL, Amaral LAN, Glass L. et al. 2000; PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 101(23): e215–220.
14. Hollweck T, Akra B, Häussler S. et al. 2011; A novel pulsatile bioreactor for mechanical stimulation of tissue engineered cardiac constructs. J Funct Biomater 2(3): 107–118.
15. Houser SR, Margulies KB. 2003; Is depressed myocyte contractility centrally involved in heart failure? Circ Res 92(4): 350–358.
16. Imsirovic J, Derricks K, Buczek-Thomas JA. et al. 2013; A novel device to stretch multiple tissue samples with variable patterns: application for mRNA regulation in tissue-engineered constructs. Biomatter 3(2): 1–7.
17. Isenberg BC, Tranquillo RT. 2003; Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann Biomed Eng 31(8): 937–949.
18. Janmey PA, Winer JP, Weisel JW. 2009; Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6(30): 1–10.
19. Kanno S, Saffitz JE. 2001; The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 10(4): 169–177.
20. Kemi OJ, Ceci M, Wisloff U. et al. 2007; Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol 214(2): 316–321.
21. Kensah G, Gruh I, Viering J. et al. 2011; A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue. Tissue Eng C Methods 17(4): 463–473.
22. Kim BS, Mooney DJ. 1998; Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res 41(2): 322–332.
23. Kim YJ, Sah RLY, Doong JYH. et al. 1988; Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174(1): 168–176.
24. Lampe PD, Cooper CD, King TJ. et al. 2006; Analysis of Connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart. J Cell Sci 119(16): 3435–3442.
25. Lampe PD, TenBroek EM, Burt JM. et al. 2000; Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 149(7): 1503–1512.
26. Lin MI, Das I, Schwartz GM. et al. 2000; Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo. Dev Biol 226(2): 180–191.
27. Minino AM, Xu J, Kenneth D. 2010; National Vital Statistics Reports Deaths: Preliminary Data for 2008. Natl Vital Stat Rep 59(2): 1–72.
28. Moss AJ, Hall WJ, Cannom DS. et al. 2009; Cardiac-resynchroniziation therapy for the prevention of heart-failure events. N Engl J Med 361(14): 1329–1338.
29. Qi X, Varma P, Newman D. et al. 2001; Gap junction blockers decrease defibrillation thresholds without changes in ventricular refractoriness in isolated rabbit hearts. Circulation 104(13): 1544–1549.
30. Radisic M, Park H, Shing H. et al. 2004; Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101(52): 18129–18134.
31. Salameh A, Wustmann A, Karl S. et al. 2010; Cyclic mechanical stretch induces cardiomyocyte orientation and polarization of the gap junction protein connexin43. Circ Res 106(10): 1592–1602.
32. Sarbassov DD, Guertin DA, Ali SM. et al. 2005; Phosphorylation and regulation of Akt/PKB by the rictor–mTOR complex. Science (NY) 307(5712): 1098–1101.
33. Segers VFM, Lee RT. 2010; Protein therapeutics for cardiac regeneration after myocardial infarction. J Cardiovasc Translat Res 3(5): 469–477.
34. Shimko VF, Claycomb WC. 2008; Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes. Tissue Eng A 14(1): 49–58.
35. Solan JL, Marquez-Rosado L, Sorgen PL. et al. 2007; Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC. J Cell Biol 179(6): 1301–1309.
36. Syedain ZH, Weinberg JS, Tranquillo RT. 2008; Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A 105(18): 6537–6542.
37. Toth MJ, Ward K, van der Velden J. et al. 2011; Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function. J Appl Physiol (Bethesda, MD) 110(4): 892–900.
38. Turner CH. 1998; Three rules for bone adaptation to mechanical stimuli. Bone 23(5): 399–407.
39. Van de Werf F, Bax J, Betriu A. et al. 2008; Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29(23): 2909–2945.
40. Wille JJ, Elson EL, Okamoto RJ. 2006; Cellular and matrix mechanics of bioartificial tissues during continuous cyclic stretch. Ann Biomed Eng 34(11): 1678–1690.
41. World Health Organization. 2008; The Top Ten Causes of Death.
42. Ye KY, Black LD. 2011; Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J Cardiovasc Translat Res 4(5): 575–591.
43. Zannad F, McMurray JJV, Krum H. et al. 2011; Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1): 11–21.
44. Zimmermann WH, Melnychenko I, Wasmeier G. et al. 2006; Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12(4): 452–458.
45. Zimmermann WH, Schneiderbanger K, Schubert P, et al. 2001; Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90(2): 223–230.